AI
Thursday, August 31, 2017 4:49:53 PM
I'm conflicted . As a CAD patient I would prefer the Rx EPA ( Vascepa ) but since my insurance provider refuses to cover.... I buy Omegia Via EPA 500.
If AMRN is able to prevent DS alternatives being sold it will be a huge win for them .
So I'll give you the Uber Bull case ....R-IT shows 20% RRR or better in MACE with at least a P value of .01 ...AND ...Amarin prevails in blocking the sale of DS alternatives .....THEN you have the proverbial 10 bagger .....angels sing and JL is crowned king .
The Uber Bear case ...R-IT shows less then 12% RRR in MACE with a P value over .04 ...AND ..Amarin loses it fight to block DS alternatives ....angels cry and PY returns to be knighted.
As a patient I'm rooting for the bulls ...just not willing to bet hard $ on it .
Kiwi
PS ... Ralphey ..I remember you from the Citizen Petition days ...
Recent AMRN News
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
